P
Peter Gæde
Researcher at University of Southern Denmark
Publications - 83
Citations - 10837
Peter Gæde is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 22, co-authored 71 publications receiving 10129 citations. Previous affiliations of Peter Gæde include Copenhagen University Hospital & Steno Diabetes Center.
Papers
More filters
Journal ArticleDOI
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
Peter Gæde,P. Vedel,Nicolai Larsen,Nicolai Larsen,Jensen G,Hans-Henrik Parving,Hans-Henrik Parving,Oluf Pedersen,Oluf Pedersen +8 more
TL;DR: A target-driven, long-term, intensified intervention aimed at multiple risk factors in patients with type 2 diabetes and microalbuminuria reduces the risk of cardiovascular and microvascular events by about 50 percent.
Journal ArticleDOI
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
TL;DR: In at-risk patients with type 2 diabetes, intensive intervention with multiple drug combinations and behavior modification had sustained beneficial effects with respect to vascular complications and on rates of death from any cause and from cardiovascular causes.
Journal ArticleDOI
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
TL;DR: Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria slows progression to nephropathy, and progression of retinopathy and autonomic neuropathy.
Journal ArticleDOI
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
Peter Gæde,Jens Oellgaard,Jens Oellgaard,Bendix Carstensen,Peter Rossing,Peter Rossing,Peter Rossing,Henrik Lund-Andersen,Henrik Lund-Andersen,Hans-Henrik Parving,Oluf Pedersen +10 more
TL;DR: At 21.2 years of follow-up of a 7.8 years intensified, multifactorial, target-driven treatment of type 2 diabetes with microalbuminuria, the patients in the intensive-therapy group survived for a median of 7.9 years of gain of life, matched by time free from incident cardiovascular disease.
Journal ArticleDOI
Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
Jakob Ek,Gregers S. Andersen,Søren A. Urhammer,Peter Gæde,Thomas Drivsholm,Knut Borch-Johnsen,T. Hansen,Oluf Pedersen +7 more
TL;DR: A widespread Gly482Ser polymorphism of PGC-1 is associated with a 1.34 genotype relative risk of Type II diabetes.